Resectable Sarcoma: Clinical Trials

2 trials for Resectable Sarcoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 2

Follow Resectable Sarcoma: new trials by email Literature Review of Resectable Sarcoma trials Research Report on Resectable Sarcoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Doxorubicin, Doxorubicin Hydrochloride, Drug Delivery Microdevice - Metastatic Sarcoma, Recurrent Sarcoma
Not applicableRecruitingM.D. Anderson Cancer Center202025-02-252026-08-11
Intravital Microscopy in Human Solid Tumors
Diagnostic Microscopy, Fluorescein Sodium Injection - Solid Tumor, Adult, Clinical Stage IV Gastric Cancer AJCC v8
Not applicableRecruitingMayo Clinic852019-02-282026-06-02

Narrower conditions

Sarcoma (2)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Stomach Neoplasms (1)

Broader conditions

Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Connective and Soft Tissue (2)  ·  Adenocarcinoma (1)  ·  Brain Diseases (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Neoplasms (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Gastrointestinal Diseases (1)

Interventions

Doxorubicin (1)  ·  Everolimus (1)  ·  Fluorescein (1)  ·  Fluoresceins (1)  ·  Ifosfamide (1)  ·  Irinotecan (1)  ·  Polyethylene Glycols (1)  ·  Sirolimus (1)  ·  Temozolomide (1)  ·  Vincristine (1)  ·  ganitumab (1)  ·  pazopanib (1)  ·  polyethylene glycol 400 (1)  ·  polyethylene glycol 8000 (1)  ·  temsirolimus (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)

Countries

United States (2)

Top investigators

Emmanuel M Gabriel, M.D., Ph.D. (1)  ·  Joseph Ludwig, MD (1)

Results publications

PMID 12001988, PMID 17704903, PMID 19906081, PMID 19917863, PMID 20061178, PMID 20233873, PMID 20336386, PMID 20374484, PMID 20490982, PMID 20737573, PMID 21153378, PMID 21909917, PMID 21926464, PMID 22162570, PMID 23456602, PMID 24956510, PMID 25013744, PMID 26883450, PMID 2801858, PMID 33654117, PMID 37124504, PMID 3808620

NIH funding

R01CA180279 (1)